Nordea Investment Management
ANAB icon

Nordea Investment Management’s AnaptysBio ANAB Stock Holding History

Nordea Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135,614
Closed -$3.36M – 897
2024
Q2 		$3.36M Buy
+135,614
New +$3.16M ﹤0.01% 607

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management's ANAB Position: Q3 2024 in Review

Nordea Investment Management sold out of AnaptysBio (ANAB) in Q3 2024, closing a stake of 135,614 shares — an estimated $3.36M sold.

Nordea Investment Management first reported a position in ANAB in Q2 2024 and held it in 1 quarter. The position peaked at $3.36M in Q2 2024. 160 funds tracked by Wall St. Rank hold ANAB as of Q3 2024.

  • Nordea Investment Management reported no remaining AnaptysBio position as of Q3 2024 after selling out during the quarter.
  • Nordea Investment Management sold 135,614 AnaptysBio shares in Q3 2024, an estimated $3.36M.
  • Nordea Investment Management first reported a position in AnaptysBio in Q2 2024 and held it in 1 quarter.
  • Nordea Investment Management's AnaptysBio position peaked at $3.36M in Q2 2024.
  • 160 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2024.

Based on Nordea Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.